Showing results (341-350 of 726) with videos related to

Sort By:
Pageof 73
Therapeutic Advances in Hematology|April 5, 2013
Symptom Burden and Quality of Life in Patients with Follicular Lymphoma undergoing Maintenance Treatment with Rituximab Compared with ObservationMark S Walker, Edward J Stepanski, Carolina Reyes, et al.
Bone Marrow Transplantation|March 24, 1998
High-dose chemotherapy with BUCY or BEAC and unpurged peripheral blood stem cell infusion in patients with low-grade non-Hodgkin's lymphomaC H Weaver, L Schwartzberg, S Rhinehart, et al.
Nanotechnology|January 12, 2010
Functional plasmonic antenna scanning probes fabricated by induced-deposition mask lithographyA Weber-Bargioni, A Schwartzberg, M Schmidt, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 24, 2007
Perturbation of B cell activation in SLAM-associated protein-deficient mice is associated with changes in gammaherpesvirus latency reservoirsIn-Jeong Kim, Claire E Burkum, Tres Cookenham, et al.
BMC Research Notes|June 22, 2012
Symptom burden & quality of life among patients receiving second-line treatment of metastatic colorectal cancerMark S Walker, Elaine Yu Pharm, Jiandong Kerr, et al.
Immunity|August 10, 2010
Follicular helper T cell differentiation requires continuous antigen presentation that is independent of unique B cell signalingElissa K Deenick, Anna Chan, Cindy S Ma, et al.
Genes & Development|November 14, 1997
Rescue of osteoclast function by transgenic expression of kinase-deficient Src in src-/- mutant miceP L Schwartzberg, L Xing, O Hoffmann, et al.
Nature Communications|July 18, 2018
Nanoscale imaging of charge carrier transport in water splitting photoanodesJohanna Eichhorn, Christoph Kastl, Jason K Cooper, et al.
Cellular Immunology|July 15, 2009
Phenotypic differences between mice deficient in XIAP and SAP, two factors targeted in X-linked lymphoproliferative syndrome (XLP)Julie M Rumble, Karolyn A Oetjen, Paul L Stein, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|August 26, 2016
Rolapitant improves quality of life of patients receiving highly or moderately emetogenic chemotherapyMartin Chasen, Laszlo Urban, Ian Schnadig, et al.
Pageof 73